Adaptive Biotechnologies ADPT Proceeds From Contributed Capital
Proceeds From Contributed Capital at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromContributedCapital.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's proceeds from contributed capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Adaptive Biotechnologies's proceeds from contributed capital?
- Adaptive Biotechnologies (ADPT) reported proceeds from contributed capital of $2.48M in Q1 2026.
- What does proceeds from contributed capital mean?
- This represents cash inflows received from equity contributions or capital injections from shareholders or other entities. It is a source of financing that does not typically involve the issuance of traditional debt or public equity markets. This metric provides insight into the company's ability to raise capital from existing stakeholders to support operations or growth initiatives.